+ -

University of Basel

Breast Cancer Research

© Shutterstock

One in eight women will develop breast cancer in her lifetime. While extensive and distressing treatments lead to a cure for the majority of patients, one in five patients dies from drug-resistant, metastatic breast cancer. Since research is and remains the most important source of hope for those affected and their families, the University of Basel, in collaboration with the University Hospital Basel, is putting a focus on breast cancer research.

In most cases, breast cancer treatment involves surgery to remove the primary tumour and cancerous lymph nodes, radiotherapy and drug treatment (e.g. chemotherapy, anti-hormone therapy, immunotherapy). This is done with the aim of killing all cancer cells and preventing the occurrence of metastases. The surgical and drug treatments in particular can cause serious and long-term suffering such as exhaustion, pain, restricted movement and sensory disturbances. This constantly and massively impairs the quality of life of the patients, which represents a great challenge for them and their social environment. It is still unclear which patients are overtreated, why and which patients relapse and how resistance can be overcome in order to cure metastatic breast cancer. Researchers at the University and the University Hospital Basel are working tirelessly to develop new therapies and treatment methods for the benefit of patients.


To top